Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | Exercise / conversionCommon Stock | 2,637 | $7.79 | $20,542.23 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 23, 2016 Filed Nov 29, 2016 00:29 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,182 | $70.19 | $223,350.31 |
DisclosureSEC source: 0001093557-16-000754 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,279 F1 · shares: On June 15, 2016, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $69.84 to $70.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| November 23, 2016 Filed Nov 29, 2016 00:27 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 10,300 | $70.32 | $724,259.95 |
DisclosureSEC source: 0001093557-16-000753 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,409 F1 · shares: On December 10, 2015 Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.73. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 23:31 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 3,417 | $62.50 | $213,562.50 |
DisclosureSEC source: 0001093557-16-000749 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,598 F1 · shares: On November 12, 2015, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 23:32 UTC |
GREGG TERRANCE HDirector · Executive Chairman
|
Disposition to issuerCommon Stock | 2,172 | $62.17 | $135,041.71 |
DisclosureSEC source: 0001093557-16-000750 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,944 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 54,313 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 20,313 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 21:07 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,182 | $81.12 | $258,109.52 |
DisclosureSEC source: 0001093557-16-000731 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 25,461 F1 · shares: On June 15, 2016, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.42 to $81.87. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 21:08 UTC |
ROPER JESSSVP, CFO
|
SaleCommon Stock | 2,471 | $80.75 | $199,544.37 |
DisclosureSEC source: 0001093557-16-000733 · edgardoc.xml · nonDerivative · entry 1 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,215 F1 · shares: On November 20, 2015, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.39 to $80.98. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 55,000 unvested restricted stock units, 30,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 5,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 21:08 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 10,300 | $81.95 | $844,065.43 |
DisclosureSEC source: 0001093557-16-000732 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,709 F1 · shares: On December 10, 2015 Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.65 to $82.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 19, 2016 Filed Oct 20, 2016 23:55 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
SaleCommon Stock | 4,997 | $82.31 | $411,303.07 |
DisclosureSEC source: 0001093557-16-000727 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,345 F1 · shares: On December 11, 2015, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 00:25 UTC |
SAYER KEVIN RDirector · President & CEO
|
SaleCommon Stock | 7,000 | $81.87 | $573,100.50 |
DisclosureSEC source: 0001093557-16-000725 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,891 F1 · shares: On December 14, 2015, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $81.07 to $82.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 160,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:59 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 3,560 | $84.41 | $300,508.14 |
DisclosureSEC source: 0001093557-16-000723 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,015 F1 · shares: On November 12, 2015, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.52 to $85.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $84.42 Strike: $7.63 | $928,579.30 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · derivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583 Underlying: Common Stock · 11,000 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | SaleCommon Stock | 11,000 | $84.42 | $928,579.30 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On March 7, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.52 to $84.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest on March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
|
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | Exercise / conversionCommon Stock | 11,000 | $7.63 | $83,930.00 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| October 10, 2016 Filed Oct 13, 2016 00:56 UTC |
GREGG TERRANCE HDirector · Executive Chairman
|
Disposition to issuerCommon Stock | 2,167 | $83.35 | $180,619.45 |
DisclosureSEC source: 0001093557-16-000721 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,116 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 59,391 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 25,391 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 21:10 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
SaleCommon Stock | 5,000 | $82.55 | $412,750.00 |
DisclosureSEC source: 0001093557-16-000717 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,342 F1 · shares: On December 11, 2015, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 23, 2016 Filed Sep 28, 2016 00:15 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 10,300 | $94.00 | $968,195.88 |
DisclosureSEC source: 0001093557-16-000715 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,009 F1 · shares: On December 10, 2015 Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $93.78 to $94.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 23, 2016 Filed Sep 28, 2016 00:14 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,182 | $93.97 | $298,999.81 |
DisclosureSEC source: 0001093557-16-000714 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 28,643 F1 · shares: On June 15, 2016, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $93.86 to $94.06. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 22, 2016 Filed Sep 23, 2016 23:52 UTC |
ROPER JESSSVP, CFO
|
SaleCommon Stock | 2,470 | $93.99 | $232,155.30 |
DisclosureSEC source: 0001093557-16-000711 · edgardoc.xml · nonDerivative · entry 1 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,686 F1 · shares: On November 20, 2015, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $93.81 to $94.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 55,000 unvested restricted stock units, 30,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 5,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 22:38 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
SaleCommon Stock | 5,000 | $92.87 | $464,366.00 |
DisclosureSEC source: 0001093557-16-000709 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,342 F1 · shares: On December 11, 2015, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.62 to $93.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:35 UTC |
SAYER KEVIN RDirector · President & CEO
|
SaleCommon Stock | 7,000 | $91.79 | $642,526.50 |
DisclosureSEC source: 0001093557-16-000705 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,891 F1 · shares: On December 14, 2015, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $90.64 to $92.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 160,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 13, 2016 Filed Sep 22, 2016 22:37 UTC |
MOY JEFFREYSVP, Operations
|
GiftCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-16-000708 · edgardoc.xml · nonDerivative · entry 1 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 50,556 F1 · shares: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. F2 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 00:30 UTC | SaleCommon Stock | 7,071 | $92.06 | $650,964.75 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · nonDerivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 3,499 F7 · price: This transaction was executed in multiple trades at prices ranging from $92.06 to $92.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 12, 2016 Filed Sep 15, 2016 00:46 UTC |
SKYLER JAY SDirector
|
SaleCommon Stock | 10,000 | $93.00 | $930,000.00 |
DisclosureSEC source: 0001093557-16-000703 · edgardoc.xml · nonDerivative · entry 1 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Daughter Disclosed balance after: 0 F1 · ownership.nature: Shares are held by Jennifer Skyler Living Trust, with respect to which the Reporting Person is a trustee. Read SEC document |
| September 12, 2016 Filed Sep 15, 2016 00:44 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 5,000 | $92.90 | $464,511.50 |
DisclosureSEC source: 0001093557-16-000702 · edgardoc.xml · nonDerivative · entry 2 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 24,304 F3 · price: This transaction was executed in multiple trades at prices ranging from $92.90 to $92.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F4 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Disposition to issuerCommon Stock | 3,525 | $93.72 | $330,372.52 |
DisclosureSEC source: 0001093557-16-000698 · edgardoc.xml · nonDerivative · entry 3 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,575 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Disposition to issuerCommon Stock | 6,114 | $93.72 | $573,020.59 |
DisclosureSEC source: 0001093557-16-000698 · edgardoc.xml · nonDerivative · entry 2 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,100 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 3,560 | $93.65 | $333,391.51 |
DisclosureSEC source: 0001093557-16-000698 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,214 F1 · shares: On November 12, 2015, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.86 to $94.57. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:51 UTC |
SKYLER JAY SDirector
|
SaleCommon Stock | 25,000 | $94.07 | $2,351,787.50 |
DisclosureSEC source: 0001093557-16-000699 · edgardoc.xml · nonDerivative · entry 1 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 17,246 F1 · price: This transaction was executed in multiple trades at prices ranging from $93.68 to $95.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
Disposition to issuerCommon Stock | 4,223 | $93.72 | $395,790.96 |
DisclosureSEC source: 0001093557-16-000697 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,582 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018, and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
Disposition to issuerCommon Stock | 4,445 | $93.72 | $416,597.40 |
DisclosureSEC source: 0001093557-16-000697 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,805 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018, and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
Disposition to issuerCommon Stock | 6,312 | $93.72 | $591,577.05 |
DisclosureSEC source: 0001093557-16-000696 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,309 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:33 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
Disposition to issuerCommon Stock | 4,001 | $93.72 | $374,984.12 |
DisclosureSEC source: 0001093557-16-000696 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,621 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:32 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
Disposition to issuerCommon Stock | 4,223 | $93.72 | $395,790.54 |
DisclosureSEC source: 0001093557-16-000695 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,342 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:32 UTC |
Balo Andrew KEVP, Clinical and Regulatory
|
Disposition to issuerCommon Stock | 4,445 | $93.72 | $416,596.96 |
DisclosureSEC source: 0001093557-16-000695 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Clinical and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,565 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:32 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Disposition to issuerCommon Stock | 3,525 | $93.72 | $330,372.52 |
DisclosureSEC source: 0001093557-16-000694 · edgardoc.xml · nonDerivative · entry 3 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,575 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:32 UTC |
LISTER JOHNGeneral Manager, EMEA
|
Disposition to issuerCommon Stock | 6,114 | $93.72 | $573,020.59 |
DisclosureSEC source: 0001093557-16-000694 · edgardoc.xml · nonDerivative · entry 2 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,100 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:32 UTC |
LISTER JOHNGeneral Manager, EMEA
|
SaleCommon Stock | 3,560 | $93.65 | $333,391.51 |
DisclosureSEC source: 0001093557-16-000694 · edgardoc.xml · nonDerivative · entry 1 LISTER JOHN · CIK 0001464741 · General Manager, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,214 F1 · shares: On November 12, 2015, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.86 to $94.57. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
Disposition to issuerCommon Stock | 3,556 | $93.72 | $333,278.63 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 6 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 50,846 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
Disposition to issuerCommon Stock | 4,445 | $93.72 | $416,596.96 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 5 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 54,402 F4 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F3 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 6,666 | $65.80 | $438,622.80 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 4 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 58,847 F1 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F3 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 8,333 | $95.80 | $798,301.40 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 3 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 52,181 F1 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F3 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 6,666 | $95.80 | $638,602.80 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 2 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,334 F1 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 61,334 unvested restricted stock units, 33,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 08, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 8,333 | $95.80 | $798,301.40 |
DisclosureSEC source: 0001093557-16-000692 · edgardoc.xml · nonDerivative · entry 1 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 F1 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 61,334 unvested restricted stock units, 33,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 08, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
ROPER JESSSVP, CFO
|
Disposition to issuerCommon Stock | 3,556 | $93.72 | $333,277.57 |
DisclosureSEC source: 0001093557-16-000693 · edgardoc.xml · nonDerivative · entry 2 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,156 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 55,000 unvested restricted stock units, 30,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 5,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:31 UTC |
ROPER JESSSVP, CFO
|
Disposition to issuerCommon Stock | 2,667 | $93.72 | $249,958.17 |
DisclosureSEC source: 0001093557-16-000693 · edgardoc.xml · nonDerivative · entry 1 ROPER JESS · CIK 0001408993 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,712 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 55,000 unvested restricted stock units, 30,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 5,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:30 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $93.66 Strike: $7.63 | $1,123,909.20 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,583 Underlying: Common Stock · 12,000 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| September 09, 2016 Filed Sep 14, 2016 00:30 UTC | Disposition to issuerCommon Stock | 4,001 | $93.72 | $374,984.12 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · nonDerivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,570 F6 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2016 Filed Sep 14, 2016 00:30 UTC | Disposition to issuerCommon Stock | 6,312 | $93.72 | $591,577.68 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · nonDerivative · entry 7 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,571 F6 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2016 Filed Sep 14, 2016 00:30 UTC | OtherCommon Stock | 7,500 | $95.80 | $718,500.00 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,883 F4 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.